Ozempic without insurance costs roughly $1,000 per month at list price, but several options can bring that number down significantly. The path you take depends on your income, your diagnosis, and how much you’re willing to pay out of pocket each month.
What Ozempic Costs Without Insurance
Novo Nordisk sets the list price for all Ozempic pen doses at $1,027.51. That’s the same whether you’re on the lowest starter dose or the highest maintenance dose. Some pharmacies list a slightly lower price around $997, but either way, you’re looking at roughly $1,000 per 28-day supply if you walk in and pay cash with no discounts applied.
That said, almost nobody should be paying full list price. Even without insurance, there are manufacturer programs, telehealth platforms, and other routes that cut costs dramatically.
Novo Nordisk’s Self-Pay Savings Program
Novo Nordisk runs a savings program through NovoCare specifically for people paying out of pocket. New patients currently pay $199 per month for the first two fills at the 0.25 mg and 0.5 mg doses. After that introductory period (or after June 30, 2026, whichever comes first), pricing shifts to $349 per month for the 0.25 mg, 0.5 mg, or 1 mg doses, and $499 per month for the 2 mg dose.
This program excludes anyone on a government insurance plan like Medicare, Medicaid, or Tricare. If you have private insurance but it simply doesn’t cover Ozempic, you may still qualify for the self-pay pricing, but check eligibility carefully. Novo Nordisk reserves the right to change these prices, so confirm the current offer at NovoCare before filling your prescription.
The Patient Assistance Program for Lower Incomes
If your household income is at or below 400% of the federal poverty level, Novo Nordisk’s Patient Assistance Program may provide Ozempic at no cost. For a single person in 2025, that threshold is roughly $62,000 per year. For a family of four, it’s around $127,000.
To qualify, you need to be a U.S. citizen or legal resident, you can’t have private prescription coverage like an HMO or PPO plan, and you generally can’t be enrolled in government programs. There are limited exceptions for Medicare patients who meet additional criteria and for people who applied for Medicaid and were denied. The application process involves income verification and a prescriber’s involvement, so expect some paperwork and a waiting period before you receive medication.
Telehealth Platforms and Compounded Semaglutide
A growing number of telehealth companies now offer semaglutide consultations and prescriptions bundled into a monthly fee. Costs vary widely depending on whether the platform prescribes brand-name Ozempic or Wegovy versus a compounded version of semaglutide.
For brand-name options, expect to pay more. Hims & Hers charges $299 to $349 per month total (including a $149 monthly membership, though the first month drops to $39). Ro’s Body program runs $344 to $494 per month with a $145 membership fee. Weight Watchers Clinic charges $273 to $423 per month with a $74 membership tied to a 12-month commitment.
Compounded semaglutide is cheaper. Mochi Health offers it at $178 per month total with a $79 membership. Henry Meds charges $199 per month with variable membership fees. Remedy Meds comes in at $299 with no membership fee at all. These prices typically include the virtual consultation, the prescription, and the medication shipped to your door.
Safety Concerns With Compounded Versions
Compounded semaglutide is not FDA-approved. That means no federal agency has reviewed it for safety, effectiveness, or quality before it reaches you. The FDA has logged 605 adverse event reports tied to compounded semaglutide as of July 2025, and several required hospitalization.
The specific problems the FDA has flagged are worth knowing about. Dosing errors are common because patients measure and inject incorrect amounts, and in some cases healthcare providers miscalculate doses. Some compounders have shipped products warm or without adequate refrigeration, which degrades the medication. Others have used salt forms of semaglutide (like semaglutide sodium or semaglutide acetate) that are chemically different from what’s in approved Ozempic, and the FDA says there’s no data confirming these salts behave the same way in your body. Perhaps most concerning, the FDA has identified outright fraudulent products with fake pharmacy names on the labels.
If you go the compounded route, verify that the pharmacy is a licensed, registered compounding facility. Be cautious of prices that seem too low, and don’t use any injectable that arrives at room temperature.
Getting a Prescription Without a Primary Care Doctor
You still need a prescription regardless of which route you choose. Ozempic is FDA-approved for type 2 diabetes, not weight loss (its sister drug Wegovy is the weight-loss-approved version, though both contain semaglutide). If you’re seeking it for blood sugar management, most prescribers will write for Ozempic specifically. If your goal is weight loss, a provider may prescribe Wegovy or, in some cases, write an off-label Ozempic prescription.
The telehealth platforms listed above include a virtual consultation as part of their service, so you don’t need an existing relationship with a doctor. You’ll typically fill out a health questionnaire, have a video or async visit with a licensed provider, and receive a prescription if you qualify. Most platforms require a BMI of 30 or higher, or 27 with a weight-related condition like high blood pressure or sleep apnea.
Buying From International Pharmacies
Ozempic is significantly cheaper in countries like Canada and Mexico, which leads some people to consider importing it. Under federal law, this is illegal in most circumstances. The FDA states that importing drugs for personal use is prohibited because those products typically haven’t gone through U.S. approval processes. Imported drugs can be refused at the border if they’re considered unapproved, mislabeled, or manufactured without meeting U.S. quality standards.
In practice, small personal-use quantities sometimes make it through customs, but there’s no legal protection if they don’t. You also have no guarantee the product is genuine, stored properly, or contains what the label claims. The financial savings come with real risk.
When a Generic Version Might Be Available
Novo Nordisk’s U.S. patent on semaglutide is set to expire in 2032. Several generic manufacturers have already reached settlement agreements with Novo Nordisk, though the specific entry dates remain confidential. In other countries, patent protections expire sooner, which may eventually put pressure on U.S. pricing. For now, no generic semaglutide is available in the United States, and it’s unlikely to arrive before the early 2030s at the earliest.
Comparing Your Realistic Options
- NovoCare self-pay program: $199/month introductory, then $349 to $499/month for brand-name Ozempic. Best for people who want the FDA-approved product and can afford mid-range pricing.
- Patient Assistance Program: Free, but limited to households under 400% of the federal poverty level with no private insurance.
- Telehealth with brand-name semaglutide: $273 to $494/month depending on the platform. Includes the prescription visit.
- Telehealth with compounded semaglutide: $178 to $299/month. Lower cost, but not FDA-approved and carries documented safety risks.
- International pharmacies: Cheaper, but illegal to import in most cases and no quality assurance.
Your best starting point is the NovoCare website, where you can check eligibility for both the savings offer and the patient assistance program. If you don’t qualify for either, a telehealth platform offering brand-name Wegovy or Ozempic gives you the most reliable product at a lower price than retail. Compounded semaglutide is the budget option, but go in with your eyes open about what the FDA has found.